A detailed history of Stifel Financial Corp transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 89,500 shares of RPTX stock, worth $100,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,500
Previous 51,700 73.11%
Holding current value
$100,240
Previous $177,000 33.9%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$1.25 - $3.97 $47,250 - $150,066
37,800 Added 73.11%
89,500 $117,000
Q3 2024

Nov 14, 2024

BUY
$2.75 - $3.99 $37,950 - $55,062
13,800 Added 36.41%
51,700 $177,000
Q2 2024

Aug 13, 2024

BUY
$3.02 - $4.7 $22,650 - $35,250
7,500 Added 24.67%
37,900 $125,000
Q1 2024

May 13, 2024

BUY
$4.53 - $8.41 $137,712 - $255,664
30,400 New
30,400 $143,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $47M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.